This study investigates the potential impact of illegal off-label promotion on the sales of the top selling pharmaceuticals in a U.S. market. Drawing from a dataset of the top 200 drugs by sales from 2004-2010, this is the first study to incorporate a measurement of illegal off-label promotion and the effect it has on the sales of drug products. The rising usage and litigation involved in off-label drug use underlines the importance of the current study. This study found that on average, a drug that is promoted for off-label uses can increase its sales by up to 18 percent.
The author has given permission for this work to be deposited in the Digital Archive of Colorado College.
Colorado College Honor Code upheld.
Includes bibliographical references.
The author has given permission for this work to be deposited in the Digital Archive of Colorado College.
Colorado College Honor Code upheld.
